Skip to content

Building capacity for patient-centered Clinical Comparative Effectiveness Research (CER) on rare lung disease

This project is funded through a Patient-Centered Outcomes Research Institute (PCORI) Eugene Washington PCORI Engagement Award (EASO-42389)

Project Information

Background +

Children’s Interstitial and Diffuse Lung Disease (chILD) includes rare pulmonary disorders that cause significant morbidity and mortality. These heterogeneous conditions vary in severity, age of onset, and prognosis, with some children requiring minimal support while others face life-threatening challenges or need lung transplantation.

Families often struggle with accessing specialized care and managing the child’s developmental and emotional needs, alongside finding effective treatments. Additionally, there is limited data on long-term outcomes, including mental health and quality of life. A collaborative, patient-centered approach is vital to address the diverse needs of this population.

Proposed Solution +

chILD disorders represent a significant unmet need in research and treatment. This project aims to establish a collaborative patient-centered clinical comparative effectiveness research program focused on chILD. By engaging patients, caregivers, and clinicians, the goal is to empower stakeholders, enhance patient care, and create sustainable research addressing the unique challenges faced by those affected by chILD.

Objective +

To establish a sustainable, patient-centered clinical comparative effectiveness research program for chILD.

Activities +

Patient-Centered Research Community

Establish a collaborative network of patients, caregivers, clinicians, and researchers from multiple chILD centers. All members will complete the PCORI Research Fundamentals curriculum and participate in chILD-specific stakeholder webinars.

SEED Method Engagement

Using the Stakeholder Engagement in question Development and Prioritization (SEED) Method, we will conduct two cycles of virtual engagement studios, focus groups, and in-person meetings. These will help generate conceptual models, prioritize research questions, and ensure that patient and caregiver perspectives guide the process.

Annual Hybrid Meeting

This event brings stakeholders together each year to prioritize research questions and develop research infrastructure and long-term plans for sustainability.

Dissemination

The research agenda and engagement strategies will be shared via virtual meetings, publications, and our website, reaching both the chILD and broader rare disease communities.

Project Outcomes +

Short-Term

During the project period

  • A diverse, engaged research community trained to participate in clinical comparative effectiveness research
  • Completion of the SEED engagement process and prioritized research questions
  • A comprehensive clinical comparative effectiveness research agenda for chILD disorders

Medium-Term

0–2 years post-project

  • Ongoing dissemination through virtual meetings, publications, and social media
  • Continued engagement of the research community and growing investment in chILD research
  • A growing network of trained stakeholders available to collaborate on future projects

Long-Term

3+ years post-project

  • A sustained program of patient-centered clinical comparative effectiveness research improving outcomes for all forms of chILD
  • Empowered patients and families actively participating in research and decision-making
  • Improved outcomes and quality of life for chILD patients across all stages of life
Patient & Stakeholder Engagement Plan +

This project involves patients, caregivers, clinicians, and researchers from the outset. A Project Oversight Team — including physicians, a parent outreach coordinator, and stakeholder leaders — guides the project’s direction.

The SEED method is used to identify key stakeholders, conduct interviews and focus groups, and prioritize research questions. Stakeholders are recruited through our Patient Advisory Council, online communities, and social media. Physicians and allied health professionals are drawn from our existing research network.

This inclusive, collaborative approach ensures that the voices of patients and families are central to the research process — because patient-centered clinical comparative effectiveness research only works when patients are genuinely at the center.

*The SEED Method was funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (#1310-07664) to Emily Zimmerman (Principal Investigator), Center on Society and Health at Virginia Commonwealth University.

Year 1 — Completed

We built the foundation.

In Year 1, we brought together families, patients, physicians, and researchers to lay the groundwork for patient-centered clinical comparative effectiveness research in chILD.

  • -Trained a diverse community of stakeholders in research fundamentals
  • -Conducted family focus groups across four chILD life-stage groups
  • -Interviewed physicians and researchers to identify clinical gaps and priorities
  • -Hosted a two-day hybrid working meeting in Denver to develop research questions together
  • -Identified key priority areas to guide Year 2
Year 2 — Now Recruiting

Now we go deeper.

Year 2 brings families together by diagnosis type to develop disease-specific research questions — and expands the conversation to include clinicians, industry partners, researchers, and policymakers.

  • – Expert Stakeholder Interviews & Focus Groups (May – Oct 2026)
  • – Disease-specific Family Topic Groups (Sept 2026 – Jan 2027)
  • – New program development working groups launching in Year 2

Your voice matters. We want you at the table.

Family Topic Group Categories

Year 2 family groups are organized by diagnosis type so families can work with others who share similar biology, research questions, and treatment pathways. Groups forming in each of the following areas:

Surfactant & Alveolar Filling Disorders SP-B, SP-C, SP-D, ABCA3, TTF-1, PAP, and related conditions
NEHI Neuroendocrine cell hyperplasia of infancy
Immune Dysregulation & Hemorrhage COPA, SAVI, pulmonary hemorrhage syndromes, and multi-system immune conditions
Airway-Centered & Environmental Post-infectious bronchiolitis obliterans (PIBO), airway-centered diseases, and exposure-related chILD
Developmental & Vascular Developmental dysplasia, pulmonary vascular disorders, alveolar simplification, and growth abnormalities

Don’t see your diagnosis listed? Sign up anyway — we want to hear from you and will do our best to connect you with the right group.

New in Year 2: Program Development Working Groups

Building directly on what families and physicians told us in Denver, we are launching two new working groups to begin developing real programs for the chILD community. These groups bring together families, clinicians, and experts to lay the groundwork for pilot programs in two areas of urgent need.

Working Group

Transition to Adulthood

Young adults with chILD often fall through the cracks when moving from pediatric to adult care — and most institutions have no formal transition program at all. This working group will help define what a real transition support program for chILD looks like and what research questions will guide it.

  • Young adults (13+) living with a chILD diagnosis
  • Parents of teens & young adults navigating this transition
  • Clinicians, social workers & transition specialists
Working Group

Undiagnosed chILD

Families living without a diagnosis face some of the most profound challenges in the chILD community — including navigating emergency care, fighting for coverage, and living with chronic uncertainty. This working group will begin building the infrastructure for a pilot program to better support these families.

  • Caregivers or patients who have been seeking a diagnosis for 1+ year
  • Clinicians with experience in rare or undiagnosed conditions
  • Researchers in diagnostics, genetics & rare disease

Working group activities and time commitments are still being finalized. Express your interest and we’ll be in touch with details.

Year 1 In-Person Meeting

Denver Working Meeting — February 2026

Denver, Colorado  ·  February 27–28, 2026

Our Year 1 culminating meeting brought the chILD community together in Denver for two days of shared learning, honest conversation, and collaborative planning. Families, patients, physicians, researchers, and Foundation staff worked side by side — in person and virtually — to take everything we heard in Year 1 focus groups and turn it into a real research agenda.

4
Family breakout groups
2
Full days of sessions
5
Priority areas identified

What we heard from families

Early Childhood (Ages 0–2) Navigating diagnosis, discharge support, and care coordination for the youngest patients
School Age (Ages 3–12) School access, social challenges, psychosocial support, and daily family life
Transition to Adulthood The critical gap in care as young people move from pediatric to adult medicine
Undiagnosed chILD Emergency care, re-evaluation protocols, and the toll of living without answers
Research Priorities Turning community insights into a concrete comparative effectiveness research roadmap for the field
Families Set the Agenda Research questions were developed and prioritized by patients and caregivers — not researchers alone

At the heart of this project is a simple but powerful idea: the people living with chILD know things that no researcher can learn from a chart. In Denver, families and patients didn’t just attend — they led. They named the gaps, shaped the questions, and set the direction for what comes next. That is the patient voice in action.

What is the SEED Method?

*The SEED Method was funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (#1310-07664) to Emily Zimmerman (Principal Investigator), Center on Society and Health at Virginia Commonwealth University.

Project Collaborators

Project Oversight Team
  • Ann Gettys, Project Lead
  • Holly James – Administrative Official
  • Elizabeth Fiorino – chILD Board member
  • Dr. Jennifer Wambach – St Louis
  • Dr Alicia Casey – BCH
  • Dr Deborah Liptzin – University of Washington
  • Dr. Gregory Sawicki – BCH for IRB support
  • Jean Schmit-Gill, Parent Community Coordinator

Evaluation and IRB oversight in Collaboration with Boston Children’s Hospital

 Stakeholder Leadership Team Members
  • Cara Favuzza- Adult patient and RN
  • Angel Melendez- RT and PCORI administrator
  • Alejandra Creixell- chILD PAC member
  • Tammy Faucheux- chILD PAC member
  • Jean Schmit-Gill, chILD PAC member, Parent Community Coordinator
Project Staff
  • Ann Gettys, Project Lead
  • Tamara Yamour, Project Coordinator
  • Alina Brennan, Research Assistant

Share this: